Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds

被引：0
|
作者：
Atatreh, Noor [1 ,2 ]
Mahgoub, Radwa E. [1 ,2 ]
Ghattas, Mohammad A. [1 ,2 ]
机构：
[1] Al Ain Univ, Coll Pharm, Abu Dhabi, U Arab Emirates
[2] Al Ain Univ, AAU Hlth & Biomed Res Ctr, Abu Dhabi, U Arab Emirates
来源：
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 2025年 / 40卷 / 01期
关键词：
Anti-viral; irreversible inhibition; covalent inhibitor; Covid-19; warheads reactivity; PEPTIDE ALDEHYDE INHIBITORS; COV M-PRO; 3C-LIKE PROTEASE; CRYSTAL-STRUCTURES; DESIGN; DISCOVERY; PROTEINASE; REVEALS; TARGET; SITE;
D O I：
10.1080/14756366.2025.2460045
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Peptidomimetic inhibitors mimic natural peptide substrates, employing electrophilic warheads to covalently interact with the catalytic Cys145 of Mpro. Examples include aldehydes, alpha-ketoamides, and aza-peptides, with discussions on their mechanisms of action, potency, and structural insights. Non-peptidomimetic inhibitors utilise diverse scaffolds and mechanisms, achieving covalent modification of Mpro.
引用
收藏
页数：26
相关论文
共 50 条
  • [1] SARS-CoV-2 main protease inhibitors: What is moving in the field of peptides and peptidomimetics?
    Algar-Lizana, Sergio
    Angeles Bonache, Maria
    Gonzalez-Muniz, Rosario
    JOURNAL OF PEPTIDE SCIENCE, 2023, 29 (05)
  • [2] Discovery of novel inhibitors of SARS-CoV-2 main protease
    Zheng, Lei
    Chen, Yanmei
    Bao, Jingxiao
    He, Liping
    Dong, Suzhen
    Qi, Yifei
    Zhang, John Z. H.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (23): : 12526 - 12534
  • [3] Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors
    Fink, Elissa A. A.
    Bardine, Conner
    Gahbauer, Stefan
    Singh, Isha
    Detomasi, Tyler C. C.
    White, Kris
    Gu, Shuo
    Wan, Xiaobo
    Chen, Jun
    Ary, Beatrice
    Glenn, Isabella
    O'Connell, Joseph
    O'Donnell, Henry
    Fajtova, Pavla
    Lyu, Jiankun
    Vigneron, Seth
    Young, Nicholas J. J.
    Kondratov, Ivan S. S.
    Alisoltani, Arghavan
    Simons, Lacy M. M.
    Lorenzo-Redondo, Ramon
    Ozer, Egon A. A.
    Hultquist, Judd F. F.
    O'Donoghue, Anthony J. J.
    Moroz, Yurii S. S.
    Taunton, Jack
    Renslo, Adam R. R.
    Irwin, John J. J.
    Garcia-Sastre, Adolfo
    Shoichet, Brian K. K.
    Craik, Charles S. S.
    PROTEIN SCIENCE, 2023, 32 (08)
  • [4] Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors
    Khatua, Kaustav
    Alugubelli, Yugendar R.
    Yang, Kai S.
    Vulupala, Veerabhadra R.
    Blankenship, Lauren R.
    Coleman, Demonta
    Atla, Sandeep
    Chaki, Sankar P.
    Geng, Zhi Zachary
    Xiao, Jing
    Chen, Peng-Hsun
    Cho, Chia-Chuan D.
    Sharma, Shivangi
    Vatansever, Erol C.
    Ma, Yuying
    Yu, Ge
    Neuman, Benjamin W.
    Xu, Shiqing
    Liu, Wenshe Ray
    ANTIVIRAL RESEARCH, 2024, 225
  • [5] Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2
    Paul, Archi Sundar
    Islam, Rajib
    Parves, Md Rimon
    Al Mamun, Abdulla
    Shahriar, Imrul
    Hossain, Md Imran
    Hossain, Md Nayeem
    Ali, Md Ackas
    Halim, Mohammad A.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (04): : 1639 - 1658
  • [6] Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors
    Kim, Hoshin
    Hauner, Darin
    Laureanti, Joseph A.
    Agustin, Kruel
    Raugei, Simone
    Kumar, Neeraj
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [7] A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease
    Geng, Zhi Zachary
    Atla, Sandeep
    Shaabani, Namir
    Vulupala, Veerabhadra
    Yang, Kai S.
    Alugubelli, Yugendar R.
    Khatua, Kaustav
    Chen, Peng-Hsun
    Xiao, Jing
    Blankenship, Lauren R.
    Ma, Xinyu R.
    Vatansever, Erol C.
    Cho, Chia-Chuan D.
    Ma, Yuying
    Allen, Robert
    Ji, Henry
    Xu, Shiqing
    Liu, Wenshe Ray
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (16) : 11040 - 11055
  • [8] Mechanistic Insights into Nitrile and Alkyne Covalent Inhibitors of the SARS-CoV-2 Main Protease
    Nandi, Ashim
    Asadi, Mojgan
    Zhang, Aoxuan
    Chu, Zhen T.
    Warshel, Arieh
    ACS CATALYSIS, 2025, 15 (02): : 1158 - 1169
  • [9] Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors
    Hoshin Kim
    Darin Hauner
    Joseph A. Laureanti
    Kruel Agustin
    Simone Raugei
    Neeraj Kumar
    Scientific Reports, 12
  • [10] Allosteric inhibitors of the main protease of SARS-CoV-2
    Samrat, Subodh Kumar
    Xu, Jimin
    Xie, Xuping
    Gianti, Eleonora
    Chen, Haiying
    Zou, Jing
    Pattis, Jason G.
    Elokely, Khaled
    Lee, Hyun
    Li, Zhong
    Klein, Michael L.
    Shi, Pei-Yong
    Zhou, Jia
    Li, Hongmin
    ANTIVIRAL RESEARCH, 2022, 205
12345